Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 301–303 of 303 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01449942	Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ)	completed	Phase 1 / Phase 2	40	Xiangya Hospital of Central South UniversityOTHER	1	Oct 10, 2011	clinicaltrials
NCT00423254	Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.	completed	Phase 1	12	Mannkind CorporationINDUSTRY	1	Aug 3, 2010